Filing Details

Accession Number:
0001493152-20-022851
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-02 20:41:44
Reporting Period:
2020-11-30
Accepted Time:
2020-12-02 20:41:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335105 Lixte Biotechnology Holdings Inc. LIXT Pharmaceutical Preparations (2834) 202903526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368556 S John Kovach 248 Route 25A, No.2
East Setauket NY 10016
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-30 21,100 $4.75 1,540,183 No 4 P Indirect By John S. Kovach Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By John S. Kovach Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Warrants to Purchase Common Stock Acquisiton 2020-11-30 21,100 $4.75 21,100 $5.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,100 2020-11-30 2025-11-30 No 4 P Indirect
Footnotes
  1. The reporting person acquired 21,100 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.